Home » Newsletters » BioWorld Science

BioWorld Science

March 23, 2011

View Archived Issues

123I-DRM-106 to be developed for SPECT imaging of amyloid plaques

Micro-NMR operated by smart phone for accurate diagnosis of malignant tumors

Pioglitazone reduces the formation of renal stones in rats

Karo Bio and Zydus Cadila extend glucocorticoid research collaboration

Benefits reported for fesoterodine in elderly patients with overactive bladder

XenoPort reports data from phase IIb arbaclofen placarbil trial in GERD

Phase IIa clinical trial of NasVax's anti-CD3 MAb immunotherapy meets all endpoints

NKTR-181 displays reduced CNS side effect potential compared to oxycodone

Six-month data show improvements in childhood hypophosphatasia with ENB-0040

Novel tubulisine derivatives for cancer prepared at KemoTech

Sanofi-aventis patents new series of tryptase inhibitors

United Therapeutics' FREEDOM-C(2) registration trial for UT-15C fully enrolled

FDA assigns PDUFA date to Shire's resubmission of Firazyr for treatment of HAE

Ipilimumab improves overall survival in phase III trial in metastatic melanoma

New phosphatidylcholine transfer protein inhibitors patented by Brigham & Women's Hospital

Intellikine scientists synthesize novel PI3K inhibitors

Alzheimer's Drug Discovery Foundation supports ADispell's neuroprotective drug research

Seattle Genetics forms antibody-drug conjugate collaboration with Abbott

Cellerant Therapeutics begins phase I/II CLT-008 trial for neutropenia in leukemia

Johns Hopkins patents novel inhibitors of LSD1 for cancer

Quest Diagnostics signs agreement to acquire Celera

Provectus and FDA hold second end-of-phase II meeting on PV-10 for melanoma

Tesaro acquires rights to Amgen's anaplastic lymphoma kinase program

Aradigm completes enrollment in phase IIb inhaled ciprofloxacin trial

Asahi Kasei obtains exclusive rights to Xiaflex for two indications in Japan

FDA extends review of Novartis's NDA for QAB-149, a once-daily bronchodilator for COPD

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...